JUBILANT PHARMOVA LIMITED — Capital/Financing Update 2021

Mar 5, 2021

==> picture [596 x 129] intentionally omitted <==

March 5, 2021

BSE Limited, National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor, Dalal Street, Fort, Bandra-Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai - 400051

Dear Sirs,

Sub: Early Redemption of 4.875% Senior Notes Due 2021 by Jubilant Pharma Limited, - wholly owned subsidiary of the Company (a company incorporated under the laws of Singapore)

We refer to our intimation dated February 3, 2021 regarding the proposed early redemption of principal amount of US$100,000,000 out of US$300,000,000 4.875% Senior Notes due 2021 (the “Notes”) issued by our material wholly-owned subsidiary, Jubilant Pharma Limited (a company incorporated under the laws of Singapore) (‘JPL’).

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that JPL has on March 5, 2021 redeemed the principal amount of US$100,000,000 out of US$300,000,000 Notes at a redemption price of 101.21875% together with the accrued interest till date. JPL had made the first early redemption of US$100,000,000 in November 2019 and the second early redemption of US$100,000,000 on January 29, 2021. After the redemption of US$100,000,000 on March 5, 2021, the Notes have been paid in full and no amount remains outstanding under the Notes.

This is for your information and record.

Thanking you,

Yours faithfully,

For Jubilant Pharmova Limited

RAJIV Digitally signed by RAJIV CHANDRAKANT CHANDRAK SHAH Date: 2021.03.05 ANT SHAH 15:55:34 +05'30' Rajiv Shah Company Secretary

==> picture [594 x 132] intentionally omitted <==